According to a new report published by Allied Market Research, titled, “Rapid Tests Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global rapid tests market size was valued at $33,329.15 million in 2020, and is projected to reach $97,606.33 million by 2030, registering a CAGR of 11.3% from 2021 to 2030.
Download Free PDF Here -
https://www.alliedmarketresearch.com/request-sample/4633
The increasing incidence of chronic diseases such as diabetes, heart disease, and cancer, increased availability of tests due to the convenience of testing, and low cost of testing are the major factors driving the market growth. quick test. In addition, other factors such as speed of analysis, specificity, and stability are driving the growth of the market worldwide. In addition, the growth in personalized care and the increase in support programs by manufacturers encourage the use of rapid testing, which improves market growth.
However, strict government regulations for the adoption of rapid testing and the recall of many products due to false results are expected to hinder market growth. The coronavirus disease (COVID-19) began in late December 2019 in the Hubei province of Wuhan, China. The virus, the severe respiratory disease coronavirus 2 (SARS-CoV-2) is transmitted among humans. The COVID-19 rapid test kit helps in the diagnosis of the corona virus and thus provides important advice for the subsequent diagnosis, treatment and treatment of COVID-19. The demand for rapid COVID-19 testing has increased with the increase in the number of COVID-19 patients.
Request Customization -
https://www.alliedmarketresearch.com/request-for-customization/4633
Key market players:
- Akers Biosciences, Inc.
- Alere Inc. (Abbott Laboratories)
- Becton, Dickinson and Company
- Bio-rad Laboratories, Inc.
- Cepheid, Inc.
- Hologic, Inc.
- Meridian Bioscience, Inc.
- OraSure Technologies, Inc
Key findings of the study:
- Based on product, the over-the-counter (OTC) rapid test product segment is expected to show the fastest rapid tests market growth, at a CAGR of 11.9% from 2021 to 2030.
- Based on application, the glucose monitoring segment held maximum global rapid tests market share in 2020 and is expected to remain dominant throughout the forecast period.
- Based on end user, the hospitals & clinicssegment exhibited growth at a CAGR of 11.8% from 2021 to 2030.
- Based on region, Asia-Pacific is projected to experience growth at the highest rate, registering a CAGR of 12.8% during the forecast period.
Buy Now -
https://www.alliedmarketresearch.com/checkout-final/ffc622cc2a0f3d53ec13c0c533fa57d2
Contact: David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
